These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36458710)

  • 21. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.
    Suberviola B; Castellanos-Ortega A; Ruiz Ruiz A; Lopez-Hoyos M; Santibañez M
    Intensive Care Med; 2013 Nov; 39(11):1945-52. PubMed ID: 23949703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study of Pentraxin 3 in diagnosing the severity and cardiovascular function of the children with sepsis].
    Kang X; Zhu Y; Zhang X
    Zhonghua Er Ke Za Zhi; 2015 Aug; 53(8):592-8. PubMed ID: 26717657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Levels of serum Pentraxin 3 in Critical Coronavirus Disease-2019 Patients.
    Moulana Z; Bagherzadeh M; Mirzakhani M; Rostami A; Mohammadnia-Afrouzi M; Shahbazi M
    Environ Sci Pollut Res Int; 2022 Dec; 29(57):85569-85573. PubMed ID: 34212320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.
    Azam TU; Shadid HR; Blakely P; O'Hayer P; Berlin H; Pan M; Zhao P; Zhao L; Pennathur S; Pop-Busui R; Altintas I; Tingleff J; Stauning MA; Andersen O; Adami ME; Solomonidi N; Tsilika M; Tober-Lau P; Arnaoutoglou E; Keitel V; Tacke F; Chalkias A; Loosen SH; Giamarellos-Bourboulis EJ; Eugen-Olsen J; Reiser J; Hayek SS;
    J Am Soc Nephrol; 2020 Nov; 31(11):2725-2735. PubMed ID: 32963090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19.
    Luo S; Vasbinder A; Du-Fay-de-Lavallaz JM; Gomez JMD; Suboc T; Anderson E; Tekumulla A; Shadid H; Berlin H; Pan M; Azam TU; Khaleel I; Padalia K; Meloche C; O'Hayer P; Catalan T; Blakely P; Launius C; Amadi KM; Pop-Busui R; Loosen SH; Chalkias A; Tacke F; Giamarellos-Bourboulis EJ; Altintas I; Eugen-Olsen J; Williams KA; Volgman AS; Reiser J; Hayek SS;
    J Am Heart Assoc; 2022 Sep; 11(18):e025198. PubMed ID: 35924778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Joint Modeling of Repeated Measurements of Different Biomarkers Predicts Mortality in COVID-19 Patients in the Intensive Care Unit.
    Tong-Minh K; van der Does Y; van Rosmalen J; Ramakers C; Gommers D; van Gorp E; Rizopoulos D; Endeman H
    Biomark Insights; 2022; 17():11772719221112370. PubMed ID: 35859926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction value of soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients - a systematic review and meta-analysis.
    Matuszewski M; Ładny J; Rafique Z; Peacock F; Pruc M; Gasecka A; Szwed P; Jankowski L; Chmielewski J; Panasiuk L; Szarpak L
    Ann Agric Environ Med; 2023 Mar; 30(1):142-147. PubMed ID: 36999867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery?
    Schultz-Swarthfigure CT; McCall P; Docking R; Galley HF; Shelley B
    Interact Cardiovasc Thorac Surg; 2021 Jan; 32(2):236-243. PubMed ID: 33236082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution.
    Sepulchre E; Pittie G; Stojkovic V; Haesbroek G; Crama Y; Schyns M; Paridaens H; de Marchin J; Degesves S; Biemar C; Boccar S; Senterre JM; Minon JM
    Acta Clin Belg; 2022 Apr; 77(2):261-267. PubMed ID: 32935644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis.
    Huang F; Li Y; Xu R; Cheng A; Lv Y; Liu Q
    Mediators Inflamm; 2020; 2020():7850179. PubMed ID: 32322165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
    Tong-Minh K; van der Does Y; Engelen S; de Jong E; Ramakers C; Gommers D; van Gorp E; Endeman H
    BMC Infect Dis; 2022 Feb; 22(1):165. PubMed ID: 35189826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Could soluble urokinase plasminogen receptor (suPAR) be used as a diagnostic biomarker for ventilator-associated pneumonia?
    Sunnetcioglu A; Sunnetcioglu M; Adıyaman F; Binici I; Soyoral L
    Clin Respir J; 2017 Nov; 11(6):925-930. PubMed ID: 26683264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited Settings.
    Chandna A; Mahajan R; Gautam P; Mwandigha L; Gunasekaran K; Bhusan D; Cheung ATL; Day N; Dittrich S; Dondorp A; Geevar T; Ghattamaneni SR; Hussain S; Jimenez C; Karthikeyan R; Kumar S; Kumar S; Kumar V; Kundu D; Lakshmanan A; Manesh A; Menggred C; Moorthy M; Osborn J; Richard-Greenblatt M; Sharma S; Singh VK; Singh VK; Suri J; Suzuki S; Tubprasert J; Turner P; Villanueva AMG; Waithira N; Kumar P; Varghese GM; Koshiaris C; Lubell Y; Burza S
    Clin Infect Dis; 2022 Aug; 75(1):e368-e379. PubMed ID: 35323932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Soluble Urokinase Plasminogen Activator Receptor as a Severity Biomarker in Children With Acute COVID-19 or Multisystem Inflammatory Syndrome.
    Louka M; Tatsi EB; Vassiliu S; Theoharis G; Straka K; Filippatos F; Dourdouna MM; Siahanidou T; Syriopoulou V; Michos A
    Pediatr Infect Dis J; 2024 May; 43(5):477-482. PubMed ID: 38251905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anakinra in hospitalized COVID-19 patients guided by baseline soluble urokinase plasminogen receptor plasma levels: A real world, retrospective cohort study.
    Segala FV; Rando E; Salvati F; Negri M; Catania F; Sanmartin F; Murri R; Giamarellos-Bourboulis EJ; Fantoni M
    PLoS One; 2023; 18(4):e0273202. PubMed ID: 37014833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-COVID Trajectory of Pentraxin 3 Plasma Levels Over 6 Months and Their Association with the Risk of Developing Post-Acute Depression and Anxiety.
    De Lorenzo R; Mazza MG; Sciorati C; Leone R; Scavello F; Palladini M; Merolla A; Ciceri F; Bottazzi B; Garlanda C; Benedetti F; Rovere-Querini P; Manfredi AA
    CNS Drugs; 2024 Jun; 38(6):459-472. PubMed ID: 38658499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
    Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
    Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
    Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
    Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.
    Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B
    J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
    Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O
    Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.